ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification

{{article.zuoZheEn}}

PDF(5457 KB)
PDF(5457 KB)
Front. Med. ›› 2023, Vol. 17 ›› Issue (4) : 685-698. DOI: 10.1007/s11684-022-0942-1
RESEARCH ARTICLE

ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2023, 17(4): 685‒698 https://doi.org/10.1007/s11684-022-0942-1

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
Share on Mendeley
PDF(5457 KB)

Accesses

Citations

Detail

Sections
Recommended

/